These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18799935

  • 1. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.
    Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S.
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):592-7. PubMed ID: 18799935
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 3. Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys.
    Binkley N, Krueger D, Engelke J, Suttie J.
    J Bone Miner Res; 2007 May; 22(5):695-700. PubMed ID: 17295605
    [Abstract] [Full Text] [Related]

  • 4. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM, Moniuszko-Jakoniuk J.
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [Abstract] [Full Text] [Related]

  • 5. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 6. Bone metabolism in galactosemia.
    Panis B, Forget PP, van Kroonenburgh MJ, Vermeer C, Menheere PP, Nieman FH, Rubio-Gozalbo ME.
    Bone; 2004 Oct; 35(4):982-7. PubMed ID: 15454106
    [Abstract] [Full Text] [Related]

  • 7. Bone turnover markers and bone mineral density in children with haemophilia.
    Tlacuilo-Parra A, Villela-Rodríguez J, Garibaldi-Covarrubias R, Soto-Padilla J, Orozco-Alcala J.
    Haemophilia; 2011 Jul; 17(4):657-61. PubMed ID: 21118337
    [Abstract] [Full Text] [Related]

  • 8. Monitoring alendronate therapy for osteoporosis.
    Braga de Castro Machado A, Hannon R, Eastell R.
    J Bone Miner Res; 1999 Apr; 14(4):602-8. PubMed ID: 10234582
    [Abstract] [Full Text] [Related]

  • 9. Relationship of bone turnover to bone density and fractures.
    Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL.
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [Abstract] [Full Text] [Related]

  • 10. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 12. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
    Kruger MC, Booth CL, Coad J, Schollum LM, Kuhn-Sherlock B, Shearer MJ.
    Nutrition; 2006 May; 22(11-12):1120-8. PubMed ID: 17030114
    [Abstract] [Full Text] [Related]

  • 13. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, Kröger H.
    J Bone Miner Res; 1999 Dec; 14(12):2002-9. PubMed ID: 10620058
    [Abstract] [Full Text] [Related]

  • 14. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
    Girgis R, Winter JS.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
    [Abstract] [Full Text] [Related]

  • 15. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 16. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

  • 17. Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.
    Tantawy AA, El Bostany EA, Matter RM, El Ghoroury EA, Ragab S, El Sherif NH.
    Platelets; 2013 Jun; 24(4):282-7. PubMed ID: 22671537
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of bone mineral density and bone metabolism in children with multiple bone fractures.
    Michałus I, Chlebna-Sokół D, Rusińska A, Jakubowska-Pietkiewicz E, Kulińska-Szukalska K.
    Ortop Traumatol Rehabil; 2008 Jun; 10(6):602-12. PubMed ID: 19153549
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 20. Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone.
    Doknic M, Maric NP, Britvic D, Pekic S, Damjanovic A, Miljic D, Stojanovic M, Radojicic Z, Jasovic Gasic M, Popovic V.
    Neuroendocrinology; 2011 Mar; 94(3):246-54. PubMed ID: 21986470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.